Research Article
Changing Trend of Neonatal Septicemia and Antibiotic Susceptibility Pattern of Isolates in Nepal
Table 3
Antibiotic sensitivity profile of gram-positive and gram-negative isolates.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Figures depict percentage, CONS: Coagulase negative staphylococci, NT: not tested, A/S: ampicillin/sulbactam, AK: amikacin, CTR: ceftriaxone, CTX: cefotaxime, COT: cotrimoxazole, CD: clindamycin, CX: cefoxitin, CFM: cefixime, COX: cloxacillin, E: erythromycin, GEN: gentamicin, MRP: meropenem, NA: nalidixic acid, OF: ofloxacin, PIT: piperacillin/tazobactam, TEI: teicoplanin, and VA: vancomycin. |